Theophylline Tablet, Extended Release
Product Images NDC 69452-267

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 69452-267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image001 (Image001)

Theophylline Extended-Release Tablets 300 mg label for oral use, distributed by Bionpharma Inc. The label shows 100 tablets per container, with storage instructions and dosage references. It includes barcodes, manufacturer location in Princeton, NJ, and a designated unvarnished area for variable batch data printing.*

FDA Label Image

Structure (Structutre0001)

Chemical structure diagram of the active ingredient theophylline, showing its molecular framework with nitrogen, oxygen, and carbon atoms, including methyl groups attached to the nitrogen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.